These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8332864)

  • 21. Cytokines: their relevance to nutrition.
    Grimble RF
    Eur J Clin Nutr; 1989 Apr; 43(4):217-30. PubMed ID: 2661214
    [No Abstract]   [Full Text] [Related]  

  • 22. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
    Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines as a key component of cancer-related inflammation.
    Germano G; Allavena P; Mantovani A
    Cytokine; 2008 Sep; 43(3):374-9. PubMed ID: 18701317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of endogenous nitric oxide on hyperoxia and tumor necrosis factor-alpha-induced leukosequestration and proinflammatory cytokine release in rat airways.
    Lin HC; Wang CH; Yu CT; Huang KS; Liu CY; Yang CW; Kuo HP
    Crit Care Med; 2003 Feb; 31(2):508-16. PubMed ID: 12576959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1--its multiple biological effects and its association with hemodialysis.
    Dinarello CA
    Blood Purif; 1988; 6(3):164-72. PubMed ID: 3293622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-4 and 13 induce the expression and release of monocyte chemoattractant protein 1, interleukin-6 and stem cell factor from human detrusor smooth muscle cells: synergy with interleukin-1beta and tumor necrosis factor-alpha.
    Bouchelouche K; Andresen L; Alvarez S; Nordling J; Nielsen OH; Bouchelouche P
    J Urol; 2006 Feb; 175(2):760-5. PubMed ID: 16407046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of cellular factors in degenerative osteoarthritis].
    Gu ZY; Wu QL; Wang GY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Mar; 28(2):123-5. PubMed ID: 8222963
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium. An in vivo study of human skin biopsies.
    Speiser W; Kapiotis S; Kopp CW; Simonitsch I; Jilma B; Jansen B; Exner M; Chott A
    Thromb Haemost; 2001 Feb; 85(2):362-7. PubMed ID: 11246561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting interleukin-1 in the treatment of rheumatoid arthritis.
    Dayer JM; Bresnihan B
    Arthritis Rheum; 2002 Mar; 46(3):574-8. PubMed ID: 11920390
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitumor effect of biological factors and their response].
    Yamazaki M
    Nihon Rinsho; 1987 May; 45(5):1144-55. PubMed ID: 2442437
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mediators in purulent meningitis].
    Faustmann PM; Dux R; Zimmermann CW
    Med Klin (Munich); 1991 May; 86(5):276. PubMed ID: 1875871
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradigm shift for graft-versus-host disease.
    Ferrara JL
    Bone Marrow Transplant; 1994 Aug; 14(2):183-4. PubMed ID: 7994229
    [No Abstract]   [Full Text] [Related]  

  • 36. [Endogenous pyrogens].
    Hurme M
    Duodecim; 1989; 105(10):894-900. PubMed ID: 2670522
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospects of new therapeutic approaches for Crohn's disease.
    Hodgson H
    Lancet; 1999 Feb; 353(9151):425-6. PubMed ID: 9989709
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of cytokines and platelet-activating factor in microvascular immune injury.
    Braquet P; Hosford D; Braquet M; Bourgain R; Bussolino F
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):88-100. PubMed ID: 2651321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical aspects: from systemic inflammation to 'immunoparalysis'.
    Volk HD; Reinke P; Döcke WD
    Chem Immunol; 2000; 74():162-77. PubMed ID: 10608087
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cytokines as inflammatory mediator].
    Ohkawara S; Goto F; Yoshinaga M
    Tanpakushitsu Kakusan Koso; 1991 May; 36(6):935-43. PubMed ID: 1866451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.